AGAP1

ArfGAP with GTPase domain, ankyrin repeat and PH domain 1, the group of ArfGAPs|BAR-PH domain containing|Ankyrin repeat domain containing

Basic information

Region (hg38): 2:235494043-236131793

Previous symbols: [ "CENTG2" ]

Links

ENSG00000157985NCBI:116987OMIM:608651HGNC:16922Uniprot:Q9UPQ3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AGAP1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGAP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
59
clinvar
18
clinvar
77
missense
115
clinvar
4
clinvar
3
clinvar
122
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
4
7
3
14
non coding
25
clinvar
6
clinvar
31
Total 0 0 116 88 28

Variants in AGAP1

This is a list of pathogenic ClinVar variants found in the AGAP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-235494699-C-G Uncertain significance (Jun 27, 2022)1971544
2-235494710-C-A Likely benign (Apr 30, 2022)2132348
2-235494722-C-T Likely benign (Jul 20, 2023)2054879
2-235494726-C-T Uncertain significance (Jul 06, 2022)2123242
2-235494727-G-A Uncertain significance (Jul 09, 2022)2060864
2-235494762-A-G Uncertain significance (Mar 01, 2022)2105333
2-235494793-G-A not specified Uncertain significance (May 23, 2023)2550706
2-235494795-G-T not specified Uncertain significance (Jan 04, 2024)2720785
2-235494818-C-T Benign (Jan 29, 2024)2013594
2-235494840-G-T Uncertain significance (Mar 12, 2023)2874891
2-235494842-C-T Likely benign (Jan 24, 2023)2060668
2-235494853-A-T Uncertain significance (Jun 29, 2023)1972441
2-235494861-G-C Likely benign (Mar 12, 2022)2110462
2-235494867-T-C Benign (Nov 23, 2023)1972969
2-235709160-G-C Likely benign (Feb 09, 2023)2824143
2-235709162-GTCC-G Likely benign (Jul 02, 2022)2078711
2-235709165-C-T Likely benign (Feb 20, 2022)2100182
2-235709168-C-G Likely benign (Jun 27, 2022)1974346
2-235709180-T-C Likely benign (Oct 19, 2022)1976317
2-235709184-T-A Uncertain significance (Jun 12, 2023)2843967
2-235709186-C-T Likely benign (Oct 30, 2023)2193917
2-235709191-A-G Uncertain significance (Jun 23, 2023)2799008
2-235709218-C-T not specified Uncertain significance (Apr 12, 2022)2367052
2-235709224-C-T Uncertain significance (Oct 15, 2023)2040856
2-235709225-G-A Benign (Jan 22, 2024)2003469

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AGAP1protein_codingprotein_codingENST00000304032 18637712
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.0001621257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.294815670.8480.00003775588
Missense in Polyphen219264.650.827522833
Synonymous-1.642832501.130.00001901723
Loss of Function5.86651.30.1170.00000313480

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005780.0000578
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00005310.0000527
Middle Eastern0.0001090.000109
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: GTPase-activating protein for ARF1 and, to a lesser extent, ARF5. Directly and specifically regulates the adapter protein 3 (AP-3)-dependent trafficking of proteins in the endosomal-lysosomal system. {ECO:0000269|PubMed:12640130}.;
Pathway
Endocytosis - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.107

Intolerance Scores

loftool
0.315
rvis_EVS
-2.39
rvis_percentile_EVS
1.1

Haploinsufficiency Scores

pHI
0.855
hipred
Y
hipred_score
0.675
ghis
0.600

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.365

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Agap1
Phenotype
vision/eye phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
protein transport;positive regulation of GTPase activity
Cellular component
nucleus;cytoplasm
Molecular function
GTPase activity;GTPase activator activity;GTP binding;phospholipid binding;metal ion binding